Korean J Med.
2018 Aug;93(4):324-335. 10.3904/kjm.2018.93.4.324.
2018 Korean Heart Rhythm Society Guidelines for Detection and Management of Risk Factors and Concomitant Cardiovascular Diseases in Korean Patients with Atrial Fibrillation
- Affiliations
-
- 1Division of Cardiology, Department of Internal Medicine, Soon Chun Hyang University Hospital, Seoul, Korea.
- 2Division of Cardiology, Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Korea. mdleeys@cu.ac.kr
- 3Division of Cardiology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.
- 4Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
- 5Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- 6Division of Cardiology, Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
- 7Division of Cardiology, Department of Internal Medicine, Inha University Hospital, Incheon, Korea.
- 8Division of Cardiac Electrophysiology, Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
- 9Division of Cardiology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- 10Divison of Cardiology, Department of Internal Medicine, The Catholic University of Korea Yeouido St. Mary's Hospital, Seoul, Korea.
- KMID: 2435068
- DOI: http://doi.org/10.3904/kjm.2018.93.4.324
Abstract
- A number of concomitant conditions and cardiovascular diseases are closely related to the development of atrial fibrillation (AF), AF recurrence, and AF-associated complications. Detection, prevention, and treatment of such conditions are essential for the prevention of AF and its disease burden. This article discusses the clinical conditions and concomitant diseases associated with AF including heart failure, hypertension, diabetes, obesity, chronic respiratory diseases, and kidney disease based on the 2016 European Society of Cardiology guidelines for the management of AF and recently updated clinical data, particularly in patients with heart failure. Furthermore, we provide recommendations for the prevention, diagnosis, and management of these conditions.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Guideline of atrial fibrillation management
- The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
- Atrial Fibrillation in Patients with Hyperthyroidism
- 2018 Korean Heart Rhythm Society Guidelines for Antiarrhythmic Drug Therapy in Non-valvular Atrial Fibrillation
- 2018 Korean Heart Rhythm Society Guidelines for The Rate Control of Atrial Fibrillation
